KEY POINTS Chronic rhinosinusitis refers to symptomatic inflammation of the nose and paranasal sinuses that has been present for a minimum of 3 months.[1][1] Its true prevalence is difficult to ...
(Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the ...
A Massachusetts man is the only one in the country who has tried a nasal spray treatment for Alzheimer's. He's going to help ...
The local nasal cavity was treated with 1 % Ephedrine Hydrochloride drops ... Classification of each type of tympanic conductance ma: p 8 Type A: normal tympanogram with a peak of -100 to +50 daPa and ...
Microbes that reside peaceably in the nasal passageways and on the skin can be harnessed for taking drugs to target cells.
The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
Parts of Massachusetts and New England felt a "once every five year" rumble and shake Monday morning when a small earthquake hit the area.According to the U.S. Geological Survey, a 3.8 magnitude ...
An earthquake off the coast of Maine rattled parts of Massachusetts around 10:22 a.m. Monday morning. According to data from the United States Geological Survey, the earthquake originated about 11 ...
Watch the video here. Residents across Massachusetts reported feeling the ground shake, disrupting the quiet of an otherwise typical start to the week. “Feel rumbling this morning?” ...
But hidden at your pharmacy among the potpourri of cough drops and cold remedies, you can find a low-risk treatment that actually may help: nasal irrigation devices. Several small studies suggest ...
The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...
Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.